Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $7.9 million.

  • Sotera Health's Share-based Compensation fell 1879.66% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year decrease of 1461.3%. This contributed to the annual value of $36.8 million for FY2024, which is 1407.97% up from last year.
  • As of Q3 2025, Sotera Health's Share-based Compensation stood at $7.9 million, which was down 1879.66% from $8.1 million recorded in Q2 2025.
  • Sotera Health's 5-year Share-based Compensation high stood at $10.2 million for Q2 2024, and its period low was $3.4 million during Q4 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $7.3 million (2023), whereas its average is $6.7 million.
  • Examining YoY changes over the last 5 years, Sotera Health's Share-based Compensation showed a top increase of 29367.37% in 2021 and a maximum decrease of 5147.82% in 2021.
  • Quarter analysis of 5 years shows Sotera Health's Share-based Compensation stood at $3.4 million in 2021, then soared by 85.03% to $6.3 million in 2022, then soared by 31.14% to $8.2 million in 2023, then decreased by 0.73% to $8.1 million in 2024, then fell by 2.39% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q3 2025, $8.1 million for Q2 2025, and $7.2 million during Q1 2025.